Axsome Therapeutics logo

Axsome Therapeutics

Brand · Biotechnology Research

3.7

Company overview

Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options.Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians.
Founded in 2012
New York, New York, USA
1.1K employees (74 in marketing)
axsome.com
64% recommend to a friend
89% positive business outlook

Salaries

Typical salary range

$175,000 – $197,500

/ yr

Help build salary transparency at Axsome Therapeutics

Share your compensation anonymously to see full data.

Contribute

People

Founders

Herriot Tabuteau
Chief Executive Officer
LinkedIn

Marketing leadership

Chris Murphy
Chris Murphy
Senior Director, Digital Products
LinkedIn
Kati Sadiwnyk
Kati Sadiwnyk
Executive Director, Payer Marketing
LinkedIn
Darren Opland
Darren Opland
Senior Director of Corporate Communications
LinkedIn
Drew Cronin-Fine
Drew Cronin-Fine
Executive Director, Marketing
LinkedIn
Cynthia North, MPA
Cynthia North, MPA
Senior Director, Consumer Marketing, Psychiatry
LinkedIn
Mohamed Lotfy
Mohamed Lotfy
Director of Marketing
LinkedIn

Hiring contacts

Michelle Gottlieb
Michelle Gottlieb
VP, HR
LinkedIn
Sarah Evarts
Sarah Evarts
Senior Manager, Human Resources Business Partner
LinkedIn
Cathlin O'Neill
Cathlin O'Neill
Human Resources Business Partner
LinkedIn

Headcount trend

Company growth over the last 12 months

Headcount +37% year over year

Funding

Total funding

$1.1B

Last raise

$570M

Post IPO Debt, 1 years ago

Funding history

May 2025

Post IPO Debt Axsome Therapeutics · $570M

Jun 2023

Post IPO Equity Axsome Therapeutics · $225M

Sep 2020

Post IPO Debt Axsome Therapeutics · $50M

Dec 2019

Post IPO Equity Axsome Therapeutics · $200M

May 2015

Venture Round Axsome Therapeutics · $2.5M

Jan 2015

Debt Financing Axsome Therapeutics · $1.3M

Audience

Monthly website visitors
31.8K
Month over month+36.3%
Quarter over quarter+22.8%
Top sourceSearch (51.2%)
Ad budget per month$0.0
Average search rank31.5
Traffic source mix
Search
51.2%
Direct
40.6%
Referral
5.7%
Paid referral
1.4%
Social
1%

LinkedIn followers

Follower count and growth

Total followers

41.5K

12-mo growth

+34%

Monthly growth

+7.8%

News

Links

axsome.comLinkedInCrunchbaseX (Twitter)
Glassdoor